Aktiechat - investeringstips
Aktiesnakken
Genmab
Bavarian Nordic
NOVO
Chemometec
Zealand Pharma
Shipping
AMBU
Banker og Finans
Biotek-snakken
ExpreS2ion
Gubra
Hansa Biopharma
EL-BILER
Grønne Aktier
TESLA
Pharma
Amerikanske aktier
BITCOIN
Laks
Danske Bank
AI/Kunstig intelligens
GN Store Nord
Krypto
OLIE OG GAS
Medico
Smallcap og First North aktier
Vestas
Ennogie
9/11 17:08 af Jan Van de Winkel |
We anticipate increased investment in our exciting product pipeline and we also are constantly scanning the landscape for potential opportunities for products or on the technology front
| |
9/11 17:07 af MrEbbe |
Genmabs report states that it currently hold a position of 5 billion dkk in cash. Can we expect a dividend, or that the money can come out "work" instead of standing there? You have previously spoken about take over possibilities of competitors, is that possibility still on the table?
| |
9/11 17:05 af Jan Van de Winkel |
No change in our guidance for 2017. We are confident in achieving our commitments and that Darzalex sales will be in our range of 1.1-1.3 bn USD.
| |
9/11 17:04 af Helge Larsen/PI-redaktør |
Can you tell us about your guiding for the hole year?
| |
9/11 17:04 af Jan Van de Winkel |
and exciting abstracts for upcoming ASH conference in December.
| |
9/11 17:04 af Jan Van de Winkel |
and we announced a potential registrational trial for that product in cervical cancer in October.
| |
9/11 17:03 af Jan Van de Winkel |
Important events: Alcyone interim data, Japan approval in RRMM, Seattle Genetics opting in for Tisotumab vedotin...
| |
9/11 17:02 af Jan Van de Winkel |
and 296 mn DKK increase in Op income to 641 mn DKK. Cash position 5.2 bn DKK
| |
9/11 17:02 af Jan Van de Winkel |
Of course, Q3 YTD revenue 1348 mn DKK up 52% year on year, expenses 707 Mn DKK up 30%....
| |
9/11 17:01 af Helge Larsen/PI-redaktør |
Great.
Can you give us a short-term update on key figures and important events in Q3?
| |
9/11 17:01 af Jan Van de Winkel |
Looking forward to the questions....
| |
9/11 17:00 af Helge Larsen/PI-redaktør |
Jan van de Winkel and David Eatwell. Welcome to Q & A here on ProInvestor.com. We are very happy to have you back here and ready to answer questions from our investors.
| |
9/11 16:58 af Jan Van de Winkel |
Good afternoon, we are waiting to take your questions at 4pm CET
| |
9/11 16:58 af Helge Larsen/PI-redaktør |
Jan and David. Are you online?
|